Free Shipping on purchases over €100

Rilastil Acnestil Gel 200 Ml

Rilastil Acnestil Gel is a product that cleanses without drying the skin. It moisturises and cleanses combination or oily skin prone to acne. It prevents and helps to combat skin blemishes caused by impurities.

SKU: 197794
-25%
20% discount.
11.30
€14.97

Pharmaceutical Care

Safe medication sales

Secure shipping

PHARMACEUTICAL RECOMMENDATION

License Number: 7270

Silvia Del Río

A pharmacist specializing in dermocosmetics, skin microbiota, and hygiene will advise and help you with the most suitable treatment.

Ask me

INFO AND TECHNICAL SPECIFICATIONS

Rilastil Acnestil Gel is formulated to cleanse skin that tends to produce large amounts of sebum or suffer from blackheads and other blemishes caused by acne.

It offers a sebum-regulating action, which helps to maintain the balance in the proportion of oil produced by the facial skin. It is also used as a keratolytic action. It helps to prevent the appearance of blackheads.

Rilastil gel contains panthenol among its ingredients, whose properties promote skin repair, soothe sunburn and dry lips, and reduce inflammation.

Hyaluronic acid helps to moisturise the skin, as well as providing an antimicrobial process that promotes the growth of skin micro-organisms.

Another of its antibacterial components is salicylic acid, which helps to renew the skin and prevents the accumulation of dead cells that can cause clogged pores.

One of its main characteristics is that it is hypoallergenic, which reduces the risk of suffering from allergies. It is non-comedogenic, soap-free, and does not contain colourings or wheat derivatives. It is clinically tested, does not contain parabens and offers an exfoliating action.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.